Field Medical Closes $40 Million Series A Financing

Field Medical Inc. has successfully closed a $40 million Series A financing round, consisting of $20 million in new capital and conversion of $20 million in seed-round debt. The funding will support completion of pilot studies for ventricular tachycardia and atrial fibrillation, continued development of the FieldForce Ablation System, and operational scale-up for the company's pivotal VT trial.